Artificial intelligence in drug development: reshaping the therapeutic landscape
Artificial intelligence (AI) is transforming medication research and development, giving clinicians new treatment options. Over the past 30 years, machine learning, deep learning, and neural networks have revolutionized drug design, target identification, and clinical trial predictions. AI has boost...
Saved in:
| Main Authors: | Sarfaraz K. Niazi, Zamara Mariam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Therapeutic Advances in Drug Safety |
| Online Access: | https://doi.org/10.1177/20420986251321704 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MACHINE INTELLIGENCE RESHAPING THE EDUCATIONAL LANDSCAPE (A THEORETICAL PERSPECTIVE)
by: Ліля Бублик, et al.
Published: (2024-10-01) -
From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes
by: Doni Dermawan, et al.
Published: (2025-06-01) -
Bridging the Regulatory Divide: A Dual-Pathway Framework Using SRA Approvals and AI Evaluation to Ensure Drug Quality in Developing Countries
by: Sarfaraz K. Niazi
Published: (2025-07-01) -
Scientific Justification and Policy Recommendations to the US Food and Drug Administration for Waiving Comparative Efficacy Studies
by: Sarfaraz K. Niazi
Published: (2025-05-01) -
Unraveling the Reshaping of Human Resource Management Function: the mediating role of artificial intelligence
by: Samuel Bangura, et al.
Published: (2025-06-01)